Mohamed Zaki

Mohamed Zaki, MD, PhD joined ADC Therapeutics in January 2023 bringing over 20 years of global biopharmaceutical experience in hematology and oncology drug development.

Dr. Zaki joined ADC Therapeutics from AbbVie where he spent the last four years, most recently as Vice President and Global Head of Oncology Development. Prior to Abbvie, he spent nine years at Celgene in increasingly senior roles in oncology and hematology development. Previously, Dr. Zaki worked in clinical development at Sanofi-Aventis and Centocor Inc., a subsidiary of Johnson & Johnson.

Dr. Zaki earned his MD and MS at Ain Shams University School of Medicine in Cairo, Egypt and his PhD from the University of Pennsylvania and Ain Shams University School of Medicine in a joint degree program. He also served on the faculty of both institutions and was a practicing physician earlier in his career.